Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein

Infection and Immunity

Volumn 68, Issue 5, 2000, Pages 2441-2448

  Degnan, B A ^a,b,c,g   Fontaine, M C ^b,c   Doebereiner, A H ^b,c   Lee, J J ^b,c   Mastroeni, P ^d,e   Dougan, G ^d   Goodacre, J A ^a,f   Kehoe, M A ^b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^g FISH Lab   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININE DEIMINASE; GLYCOPROTEIN; PHYTOHEMAGGLUTININ;

ARTICLE; BACTERIUM MUTANT; CELL PROLIFERATION; DNA SEQUENCE; ENZYME ACTIVITY; EPITHELIUM CELL; GENE CONSTRUCT; GENE INSERTION; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ARGININE; BACTERIAL PROTEINS; CELL DIVISION; CITRULLINE; EPITHELIAL CELLS; GLYCOPROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKOCYTES, MONONUCLEAR; MITOGENS; MUTAGENESIS; PHYTOHEMAGGLUTININS; STREPTOCOCCUS PYOGENES;

EID: 0034098912     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.5.2441-2448.2000     Document Type: Article

References (57)

1. Albina, J. E., C. D. Mills, and M. D. Caldwell. 1990. Alterations in macrophage physiology associated with the metabolism of L-arginine through the oxidative L-arginine deiminase pathway, p. 243-248. In S. Moncada and E. A. Higgs (ed), Nitric oxide from L-arginine: a hioregulatory system. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
2. Ashbaugh, C. D., H. B. Warren, V. J. Carey, and M. R. Wessels. 1998. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Investig. 102:550-560.
3. Bairoch, A., and R. Apweiler. 1996. The SWISS-PROT protein sequence data hank and its new supplement TrEMBL. Nucleic Acids Res. 24:21-25.
4. Baur, H., E. Luethi, V. Stalon, A. Mercenier, and D. Haas. 1989 Sequence analysis and expression of the arginine-deiminase and carbamate-kinase genes of Pseudomonas aeruginosa. Eur. J. Biochem. 179:53-60.
5. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
6. Bisno, A. L. 1991. Group A streptococcal infections and rheumatic fever. N. Engl. J. Med. 325:783-793.
7. Bisno, A. L. 1993. Acute rheumatic fever: a present-day perspective. Medicine 72:278-283.
8. Brook, I., and F. Leyva. 1981. The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin. Chemotherapy 27:360-367.
9. Burne, R. A., D. T. Parsons, and R. E. Marquis. 1989. Cloning and expression in Escherichia coli of the genes of the arginine deiminase system of Streptococcus sanguis NCTC 10904. Infect. Immun. 57:3540-3548.
10. Casiano-Colon, A., and R. E. Marquis. 1988. Role of arginine deiminase system in protecting oral bacteria and an enzymatic basis for acid tolerance. Appl. Environ. Microbiol. 54:1318-1324.
11. Cue, D. R., and P. P. Cleary. 1997. High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect. Immun. 65:2759-2764.
12. Cue, D., P. E. Dombek, H. Lam, and P. P. Cleary. 1998. Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect. Immun. 66:4593-4601.
13. Cunin, R., N. Glansdorff, A. Pierard, and V. Stalon. 1986. Biosynthesis and metabolism of arginine in bacteria. Microbiol. Rev. 50:314-352.
14. Curran, T. M., J. Lieou, and R. E. Marquis. 1995. Arginine deiminase system and acid adaptation of oral streptococci. Appl. Environ. Microbiol. 61:4494-4496.
15. Dassy, B., and J. E. Alouf. 1983. Growth of Streptococcus pyogenes and streptolysin O production in complex and synthetic media. J. Gen. Microbiol. 129:643-651.
16. Degnan, B. A., M. A. Kehoe, and J. A. Goodacre. 1997. Analysis of human T cell responses to group A streptococci using fractionated Streptococcus pyogenes proteins. FEMS Immunol. Med. Microbiol. 17:161-170.
17. Degnan, B. A., J. M. Palmer, T. Robson, C. E. D. Jones, M. Fischer, M. Glanville, G. D. Mellor, A. G. Diamond, M. A. Kehoe, and J. A. Goodacre. 1998. Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect. Immun. 66:3050-3058.
18. D'Hooghe, I., C. V. Wauven, J. Michiels, C. Tricot, P. De Wilde, J. Vanderleyden, and V. Stalon. 1997. The arginine deiminase pathway in Rhizobium etli: DNA sequence analysis and functional study of the arcABC genes. J. Bacteriol. 179:7403-7409.
19. Dombek, P. E., D. Cue, J. Sedgewick, H. Lam, S. Ruschkowski, B. B. Finlay, and P. P. Cleary. 1999. High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol. Microbiol. 31:859-870.
20. Fluckiger, U., K. F. Jones, and V. A. Fischetti. 1998. Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells. Infect. Immun. 66:974-979.
21. Ginsburg, I. 1972. Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. J. Infect. Dis. 126:294-340.
22. Ish-Horowicz, D., and J. F. Burke. 1981. Rapid and efficient cosmid cloning. Nucleic Acids Res. 9:2989-2998.
23. Kanaoka, M., C. Kawanaka, T. Negoro, Y. Fukita, K. Taya, and H. Agui. 1987. Cloning and expression of the antitumour glycoprotein gene of Streptococcus pyogenes Su in Escherichia coli. Agric. Biol. Chem. 51:2641-2648.
24. Kanaoka, M., T. Negoro, C. Kawanaka, H. Agui, and S. Nabeshima. 1991. Streptococcal antitumour protein: expression in Escherichia coli cells and properties of the recombinant protein. Agric. Biol. Chem. 55:743-750.
25. Knodler, L. A., P. J. Schofield, A. A. Gooley, and M. R. Edwards. 1997. Giardia intestinalis: purification and partial amino acid sequence of arginine deiminase. Exp. Parasitol. 85:77-80.
26. LaPenta, D., C. Rubens, E. Chi, and P. P. Cleary. 1994. Group A streptococci efficiently invade human respiratory epithelial cells. Proc. Natl. Acad. Sci. USA 91:12115-12119.
27. Luthi, E., H. Baur, M. Gamper, F. Brunner, D. Villeval, A. Mercenier, and D. Haas. 1990. The arc operon for anaerobic arginine catabolism in Pseudomonas aeruginosa contains an additional gene, arcD, encoding a membrane protein. Gene 87:37-43.
28. Mercenier, A., V. Stalon, J.-P. Simon, and D. Haas. 1982. Mapping of the arginine deiminase gene in Pseudomonas aeruginosa. J. Bacteriol. 149:787-788.
29. Michie, C., A. Scott, J. Cheesbrough, P. Beverley, and G. Pasvol. 1994. Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo. Clin. Exp. Immunol. 98:140-144.
30. Mickelson, M. N. 1964. Chemically defined medium for growth of Streptococcus pyogenes. J. Bacteriol. 88:158-164.
31. Misawa, S., M. Aoshima, H. Takaku, M. Matsumoto, and H. Hayashi. 1994. High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J. Biotechnol. 36:145-155.
32. Miyazaki, K., H. Takaku, M. Umeda, T. Fujita, W. Huang, T. Kimura, J. Yamashita, and T. Horio. 1990. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res. 50:4522-4527.
33. Myers, B. M., P. S. Tietz, J. E. Tarara, and N. F. LaRusso. 1995. Dynamic measurements of the acute and chronic effects of lysosomotropic agents on hepatocyte lysosomal pH using flow cytometry. Hepatology 22:1519-1526.
34. Ogburn, C. A., T. N. Harris, and S. Harris. 1958. Extracellular antigens in steady-state cultures of the hemolytic Streptococcus: production of proteinase at low pH. J. Bacteriol. 76:142-151.
35. Oginsky, E. L. 1957. Isolation and determination of arginine and citrulline. Methods Enzymol. 3:639-643.
36. Ohkuma, S., and B. Poole. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75:3327-3331.
37. Osterlund, A., and L. Engstrand. 1995. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol. 115:685-688.
38. Osterlund, A., and L. Engstrand. 1997. An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium: studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol. 117:883-888.
39. Osterlund, A., R. Popa, T. Nikkila, A. Scheynius, and L. Engstrand. 1997. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 107:640-647.
40. Ozeri, V., I. Rosenshine, D. F. Mosher, R. Fassler, and E. Hanski. 1998. Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1. Mol. Microbiol. 30:625-637.
41. Pichichero, M. E. 1993. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr. Infect. Dis. J. 12:268-274.
42. Rammelkamp, C. H., and R. S. Weaver. 1953. Acute glomerulonephritis. The significance of the variation in the incidence of the disease. J. Clin. Investig. 320:345-358.
43. Reizer, J., M. J. Novotny, C. Panos, and M. H. Saier, Jr. 1983. Mechanism of inducer expulsion in Streptococcus pyogenes: a two-step process activated by ATP. J. Bacteriol. 156:354-361.
44. van de Rijn, I., and R. E. Kessler. 1980. Growth characteristics of group A streptococci in a new chemically defined medium. Infect. Immun. 27:444-448.
45. Rogers, A. H., P. S. Zilm, N. J. Gully, and A. L. Pfennig. 1988. Response of a Streptococcus sanguis strain to arginine-containing peptides. Infect. Immun. 56:687-692.
46. Roos, K., E. Grahn, S. E. Holm, H. Johansson, and L. Lind. 1993. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int. J. Pediatr. Otorhinolaryngol. 25:141-148.
47. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
48. Schimke, R. T., C. M. Berlin, E. W. Sweeney, and W. R. Carroll. 1966. The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07. J. Biol. Chem. 241:2228-2236.
49. Shibatani, T., T. Kakimoto, and I. Chibata. 1975. Crystallization and properties of L-arginine deiminase of Pseudomonas putida. J. Biol. Chem. 250: 4580-4583.
50. Simon, D., and J. J. Ferretti. 1991. Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol. Lett. 82:219-224.
51. Simon, J.-P., B. Wargnies, and V. Stalon. 1982. Control of enzyme synthesis in the arginine deiminase pathway of Streptococcus faecalis. J. Bacteriol. 150:1085-1090.
52. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-507.
53. Stollerman, G. H. 1991. Rheumatogenic streptococci and autoimmunity. Clin. Immunol. Immunopathol. 61:131-142.
54. Stromberg, A., A. Schwan, and O. Cars. 1988. Five versus ten days treatment of group A streptococcal pharynotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand. J. Infect. Dis. 20: 37-46.
55. Weickmann, J. L., and D. E. Fahrney. 1977. Arginine deiminase from Mycoplasma arthritidis. Evidence for multiple forms. J. Biol. Chem. 252:2615-2620.
56. Yoshida, J., S. Takamura, and S. Suzuki. 1994. Evidence for the involvement of sulfhydryl groups in the expression of antitumor activity of streptococcal acid glycoprotein (SAGP) purified from crude extract of Streptococcus pyogenes. Anticancer Res. 14:1833-1838.
57. Yoshida, J., S. Takamura, S. Suzuki, and M. Nishio. 1996. Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein. Br. J. Cancer 73:917-923.